• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp184Tyr (c.550G>T); Zygosity=Unspecified (PubMed=1373872).
  

PubMed=3927997; DOI=10.1182/blood.V66.3.548.548
Durie B.G.M., Vela E.E., Baum V., Leibovitz A., Payne C.M., Richter L.C., Grogan T.M., Trent J.M.
Establishment of two new myeloma cell lines from bilateral pleural effusions: evidence for sequential in vivo clonal change.
Blood 66:548-555(1985)

PubMed=1373872
Mazars G.-R., Portier M., Zhang X.-G., Jourdan M., Bataille F.-R., Theillet C., Klein B.
Mutations of the p53 gene in human myeloma cell lines.
Oncogene 7:1015-1018(1992)

DOI=10.1007/0-306-46877-8_4
Jernberg-Wiklund H., Nilsson K.
Multiple myeloma cell lines.
(In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000)

PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2
Drexler H.G., Matsuo Y.
Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.
Leuk. Res. 24:681-703(2000)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)